RIPK pathway, as a potential target, for cancer treatment - a review
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Príomhchruthaitheoir: | Jahan, Nusrat |
---|---|
Rannpháirtithe: | Chowdhury, Namara Mariam |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2024
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/22051 |
Míreanna comhchosúla
-
A review on triple-negative breast cancer and its potential treatment
de réir: Niasa, Jannatul Ferdous
Foilsithe / Cruthaithe: (2023) -
A review on potential of PARP inhibitors in the treatment of prostate cancer
de réir: Islam, Saidul
Foilsithe / Cruthaithe: (2022) -
A comprehensive review on drug repurposing in cancer treatment
de réir: Sarkar, Onusree
Foilsithe / Cruthaithe: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
de réir: Meem, Manila
Foilsithe / Cruthaithe: (2023) -
Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
de réir: Chakraborty, Anuradha
Foilsithe / Cruthaithe: (2024)